QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:ATNF

180 Life Sciences (ATNF) Stock Forecast, Price & News

$1.19
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.13
$1.24
50-Day Range
$0.97
$1.89
52-Week Range
$0.94
$39.80
Volume
112,703 shs
Average Volume
1.85 million shs
Market Capitalization
$4.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

180 Life Sciences MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.50mentions of 180 Life Sciences in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$65,421 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars


ATNF stock logo

About 180 Life Sciences (NASDAQ:ATNF) Stock

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ATNF Stock News Headlines

Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Update
Why Is 180 Life Sciences (ATNF) Stock Up 30% Today?
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
See More Headlines

ATNF Price History

ATNF Company Calendar

Today
6/02/2023
Next Earnings (Estimated)
6/05/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ATNF
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-38,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.72 per share

Miscellaneous

Free Float
3,902,000
Market Cap
$4.94 million
Optionable
Not Optionable
Beta
0.53

Key Executives

  • Jim N. WoodyJim N. Woody
    Chief Executive Officer & Director
  • Ozan PamirOzan Pamir
    Chief Financial Officer
  • Jonathan B. Rothbard
    Chief Scientific Officer
  • Jason Assad
    Director-Investor Relations













ATNF Stock - Frequently Asked Questions

Should I buy or sell 180 Life Sciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 180 Life Sciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ATNF shares.
View ATNF analyst ratings
or view top-rated stocks.

How have ATNF shares performed in 2023?

180 Life Sciences' stock was trading at $3.39 at the beginning of the year. Since then, ATNF shares have decreased by 64.9% and is now trading at $1.19.
View the best growth stocks for 2023 here
.

Are investors shorting 180 Life Sciences?

180 Life Sciences saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 95,400 shares, a drop of 13.2% from the April 30th total of 109,900 shares. Based on an average daily trading volume, of 871,400 shares, the days-to-cover ratio is currently 0.1 days. Approximately 2.0% of the shares of the company are sold short.
View 180 Life Sciences' Short Interest
.

When is 180 Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 5th 2023.
View our ATNF earnings forecast
.

When did 180 Life Sciences' stock split?

Shares of 180 Life Sciences reverse split on Monday, December 19th 2022. The 1-20 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is 180 Life Sciences' stock symbol?

180 Life Sciences trades on the NASDAQ under the ticker symbol "ATNF."

Who are 180 Life Sciences' major shareholders?

180 Life Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (3.06%), Cubist Systematic Strategies LLC (0.63%), Two Sigma Investments LP (0.38%) and Simplex Trading LLC (0.00%). Insiders that own company stock include James N Woody, Jr Donald A Mcgovern, Marlene Krauss, Ozan Pamir, Pamela G Marrone and Quan Anh Vu.
View institutional ownership trends
.

How do I buy shares of 180 Life Sciences?

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 180 Life Sciences' stock price today?

One share of ATNF stock can currently be purchased for approximately $1.19.

How much money does 180 Life Sciences make?

180 Life Sciences (NASDAQ:ATNF) has a market capitalization of $4.94 million. The company earns $-38,730,000.00 in net income (profit) each year or ($7.20) on an earnings per share basis.

How can I contact 180 Life Sciences?

180 Life Sciences' mailing address is 30 PARK PLACE SUITE 45E, NEW YORK NY, 10007. The official website for the company is www.kblmerger.com. The company can be reached via phone at (650) 507-0669 or via email at jason@180lifesciences.com.

This page (NASDAQ:ATNF) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -